glp-1 drug market share of RAs in 2016 and 2017 New Demand in an Old

Theres no need to wait for brenipatide to enter the market

These medications mimic or enhance the action of natural incretins and are prescribed for type 2 diabetes management and, in some cases, weight management

10.1016/j.jacbts.2018.09.004 64 RobinsonE.CassidyR

Reassuring clinical data are starting to accrue: two multinational population-based cohort studies found no increased risk of major congenital malformations, live births, pregnancy losses, and pregnancy terminations during the periconceptional period with GLP-1 RAs [139]

Alanine scanning studies have identified specific amino acids, including His7, Gly10, Phe12, Thr13, Asp15, Phe28, and Ile29, that play crucial roles in receptor binding and activation

And others might prefer that two-month buffer period, just to be sure